Friday, 9 June 2017
Eris Lifesciences IPO price band will be at Rs 603: CMD Amit Bakshi
In a chat with ET Now, Amit Bakshi, CMD, Eris Lifescience said that the company is trying to be a significant player on therapy areas and the FCF conversion from EBITDA is very high. Edited excerpt:
You can read more here: Eris Lifesciences IPO price band will be at Rs 603: CMD Amit Bakshi
Subscribe to:
Post Comments (Atom)
Life insurers earn more in Oct selling lesser policies
The 24-company Indian life insurance industry closed last month with new business of Rs 22,776.03 crore, up by 31.87 per cent over the prev...
No comments:
Post a Comment